Shiunko is a typical Kampo drug made from herbal extracts and used to treat a range of conditions including atopic dermatitis. Shiunko, white petrolatum and 3.5% salt water were applied to the skin of atopic dermatitis patients, and their clinical effectiveness, and the changes in bacterial species and cell numbers on the skin were studied. Staphylococcus aureus was the main species seen but several other coagulase-negative staphylococci were also identified on some patients. Shiunko was clinically effective in four of seven patients (57%) compared with no patients for petrolatum and one of seven (14%) for salt water. Bacterial counts were reduced with Shiunko in four of seven patients compared with one of seven patients (14%) for both petrolatum and salt water. The results suggest that Shiunko may have antibacterial effects on staphylococci, and may be an effective treatment for atopic dermatitis and other skin infections caused mainly by Staphylococcus species.
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INTRODUCTION
The use of Kampo drugs to treat skin diseases has increased steadily since these drugs were approved by the Japanese Healthcare System (JHS) in 1976. Kampo drugs are prepared from the combined extracts of several herbs. and patients' subjective symptoms are fully considered when deciding which preparation to use. Shiunko is a typical Kampo ointment, recognized by the JHS; it has many different effects and has often been used for patients with burns and haemorrhoids, and more recently for the treatment of atopic dermatitis.t-" Shiunko (per 100 g) is composed of 71.2 g extract (from 100 g Oleum sesami, 10 g Lithospermi radix and 10 g Angelicae radix), 27.0 g of Cera alba and 1.8 g of Adeps suillus. Lithospermi radix has antibacterial and antiinflammatory activities, while Angelicae radix has anti-inflammatory, anti-allergenic and moisture-retaining activities,' and some studies have reported a correlation between these ingredients and clinical effectiveness against atopic dermatitis.i-"
Of the many reported studies on the sensitivity of bacterial strains to antimicrobials," few have referred to Kampo drugs." In the present study, the effects of treatment with Shiunko on patients with atopic dermatitis and the antibacterial activity of Shiunko against staphylococci from atopic dermatitis patients were evaluated.
PATIENTS AND METHODS

PATIENTS
The clinical effects of Shiunko on seven patients with atopic dermatitis were studied. Informed consent was obtained from each patient or their parents before participation, and the study was carried out in accordance with the Declaration of Helsinki. The diagnosis of atopic dermatitis was made according to the criteria of the Japanese Dermatological Association. The criteria were: (A) pruritus; (B) typical morphology and distribution (eczematous dermatitis and distribution); and (C) chronic or chronically relapsing course (usually coexistence of old and new lesions).
PROCEDURE
The severity of atopic dermatitis was classified as: (a) mild, less than 25% of skin affected by lesions at the sites tested (right upper arm, left forearm, or right forearm); (b) moderate, 25 -50% of skin affected by lesions; (c) severe, more than 50% of skin affected by lesions. An improvement in the skin rash was considered to be a clinical effect. Bacterial swabs were obtained from the skin of seven atopic dermatitis patients before and after 3 weeks' topical application of Shiunko, white petrolatum or 3.5% salt water. Shiunko, white petrolatum and 3.5% salt water were painted, respectively, onto the right upper arm, left forearm and right forearm of each patient twice a day for 3 weeks. The severity of atopic dermatitis at each of the three sites had been stable in the period leading up to the trial. Further, any previously used ointments were continued in the local areas with the exception of the test sites.
BACTERIAL IDENTIFICATION AND COUNTS
Bacteria were collected from the skin of atopic dermatitis patients by pressing film stamp check (FSC) mannit salt agar (Eiken Kagaku Co, Tokyo, Japan) on the skins. After overnight culture at 37°C, the colour and size of colonies grown on the medium were noted, and one or two of them were picked up and subcultured on Heart Infusion Agar (Nissui Pharmaceutical Co, Tokyo, Japan) at 37°C for 24 h. The colonies confirmed by Gram-stain were suspended in rabbit plasma solution. If fibrin was detected in the solution, the colony was identified as Staphylococcus aureus, or if no fibrin was detected, it was identified as coagulasenegative staphylococci. Coagulase-negative staphylococci were identified by 19 biochemical tests based on API STAPH (bioMerieux S.A. l'Etoile, France). After overnight culture at 3TC, we calculated the number of colony forming units (CFU)/IOcm 2 on FSC mannit salt agar. The numbers of each species of staphylococci were shown as low (+), moderate (++) or high (+++), indicating 1 to 50, 51 to 500 and over 500 CFU/I0 cm-, respectively.
STATISTICAL ANALYSIS
Comparisons of clinical and bacteriological effects between Shiunko, white petrolatum and 3.5% salt water were made using Student's t-test for paired data.
RESULTS
The staphylococcal species on the skin of seven atopic dermatitis patients and the severity of atopic dermatitis are shown in Table 1 . Of the seven atopic dermatitis patients, four (cases 2, 3, 6 and 7) showed a clinical effect to treatment with Shiunko and one (case 7) showed a clinical effect to the salt water. Shiunko was significantly more clinically effective than either white petrolatum (P < 0.01, paired t-test) or salt water (P < 0.05, paired t-test). Atopic dermatitis became more severe in one patient treated with white petrolatum (patient 5) and in two treated with salt water (29%, patients 5 and 6). Reduced bacterial counts were seen in four patients treated with Shiunko (patients 2, 3, 5 and 7), one treated with white petrolatum (patient 4) and one treated with salt water (patient 3). Bacterial counts declined significantly more often with Shiunko than with white 
DISCUSSION
Four patients treated with Shiunko showed decreased numbers of staphylococci and none showed increased numbers. Treatment with 3.5% salt water was less effective than Shiunko, because S. aureus is salt tolerant and can grow on medium containing 7% salt. Similarly, as expected, white petrolatum was less effective than Shiunko since it is a protective material with little bactericidal action. Higher concentrations of salt water might have bactericidal effects and inhibit the growth of some Staphylococcus species, but side-effects such as skin irritation might also occur.
Two of the skin areas treated carried moderate or high numbers of S. haemolyticus alone, and one skin area carried small numbers of S. haemolyticus with S. capitis. It is not clear whether these coagulasenegative staphylococci might become the chief pathogen. Many studies of the infections caused by coagulase-negative staphylococci have been reported," but the pathological significance of these organisms has not been established.
None of the patients had skin free of atopic dermatitis lesions after any of the treatments; however, clinical effects were seen in four ofthe seven patients (57%) after Shiunko treatment, and one of seven patients (14 %) after treatment with salt water. Both clinical efficacy and reduced bacterial counts were seen more often after Shiunko than after petrolatum or salt water. When atopic dermatitis was more severe, bacterial counts were generally higher, but clinical efficacy was not always proportional to the bacterial count. It may be necessary to apply Shiunko for longer than 3 weeks to achieve a clinical effect or to see this relationship. Further longer term studies evaluating treatment of patients with Shiunko should be carried out.
Shiunko is an economical ointment which does not induce undesirable side-effects such as rosacea-like derrnatitis;' it may prove effective against many skin infections whose main causative agents are S. aureus or other coagulase-negative staphylococci. Shiunko may have antibacterial activity, and may prove effective for treating infected cysts or secondary infections caused mainly by S. aureus or coagulase-negative staphylococci. Shiunko treatment regimens must be carefully followed, with routine bacterial examinations, to avoid the development of bacteria with multiple drug resistance.
